Human Factor VII (Factor 7) ELISA Kit

$438.00

Catalog Number: EF1007-1

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.
Product Size:96 Well Plate

Catalog Number. EF1007-1 Categories: , , Tags: , , , , Brand:

Additional information

Format

Sandwich ELISA

Entrez Gene

2155

Components

Biotinylated Human Factor VII Antibody, Chromogen Substrate (1x), Human Factor VII Microplate, Human Factor VII Standard, MIX Diluent Concentrate (10x), Sealing Tapes, SP Conjugate (100x), Stop Solution (1x), Wash Buffer Concentrate (20x)

TIme

4 hours

Sensitivity

2.3 ng/ml

Range

3.125 – 200 ng/ml; 6.25 – 400 mIU/ml

Samples Type

Plasma, Serum

Associated Disease

Blood Disorder

Species

Human

UniProt

P08709

Storage

Refer to component labels for details

Plex

1

Usage

For Research Use Only, Not To Be Used For Diagnostic Purposes

Documentation

Publications (18 results)

Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.

Plasma factor VII and histidine-rich glycoprotein as a potential markers in pre eclampsia

  • https://journals.ekb.eg/article_9539.html
  • SM Abdel Aty, BA El Sharawy… - The Egyptian Journal …, 2018 - journals.ekb.eg
  • Background: Preeclampsia (PE) is a complex and serious multi-system disorder of pregnancy with a worldwide incidence of 5-7% and contributes significantly to maternal and perinatal …

Indicators of Endothelial dysfunction and factors hemostasis in patients with stable and unstable atherosclerotic plaques

Indicator of endothelial dysfunction and factors hemostasis in patients iwht stable and unstable atherosclerotic plates

Novel mutation in coagulation factor VII (Carmel mutation): Identification and characterization

Association of some hemostasis and endothelial dysfunction factors with probability of presence of vulnerable atherosclerotic plaques in patients with coronary atherosclerosis

The Ratio of Factor VIIa:Tissue Factor Content within Microvesicles Determines the Differential Influence on Endothelial Cells

Apixaban Suppresses the Release of TF-Positive Microvesicles and Restrains Cancer Cell Proliferation through Directly Inhibiting TF-fVIIa Activity

Interrelation of genetic prothrombotic polymorphisms with the state of thrombocytic and plasma links of hemostasis in patients with a functionally single ventricle of the heart

Usefulness and accuracy of the international normalized ratio and activity percent of prothrombin time in patients with liver disease

A novel missense mutation close to the charge-stabilizing system in a patient with congenital factor VII deficiency

R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study

Long-Acting Coagulation Factors and Methods of Producing Same

Tissue factor in predicted severe acute pancreatitis

Cell culture processes

Activated protein C ratio, plasma tissue factor activity and activated factor VII in Chinese patients with coronary heart disease

Cellular effects of tissue factor binding proteins. University of South Florida

* Gennadievna LY (2018) Interrelation of genetic prothrombotic polymorphisms with the state of thrombocytic and plasma links of hemostasis in patients with a functionally single ventricle of the heart. Tomsk National Research Medical Center of the Russian Academy of Sciences

Loading data...